Xinyue Chen

HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study

Peng Hu, Jia Shang, Wenhong Zhang et al. · Journal of Clinical and Translational Hepatology · 2018 · 165 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Rong Fan, Jian Sun, Quan Yuan et al. · Gut · 2015 · 125 citations · Full text

Pharmacy, Immunology, Pharmacology +17

A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated‐interferon alpha

Zhenhuan Cao, Yali Liu, Lina Ma et al. · Hepatology · 2017 · 115 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients

Xiangsheng Xu, Qinghua Shang, Xinyue Chen et al. · Cellular and Molecular Immunology · 2015 · 111 citations · Full text

Life Sciences, Immunology, Internal Medicine +15

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

Rong Fan, Bin Zhou, Min Xu et al. · Clinical Gastroenterology and Hepatology · 2019 · 98 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17